Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Nuclear Medicine Therapeutics for these regions, from 2012 to 2023 (forecast), covering
China
USA
Europe
Japan
Korea
India
Global Nuclear Medicine Therapeutics market competition by top manufacturers/players, with Nuclear Medicine Therapeutics sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
IBA Group
Lantheus Medical Imaging
Triad Isotopes
Siemens Healthcare (PETNET Solutions)
NTP Radioisotopes
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Alpha Emitters
Beta Emitters
Brachytherapy
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Nuclear Medicine Therapeutics for each application, including
Application 1
Application 2
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Nuclear Medicine Therapeutics Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Alpha Emitters Market Performance (Volume)
2.1.2 Beta Emitters Market Performance (Volume)
2.1.3 Brachytherapy Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.1.1 Alpha Emitters Market Performance (Value)
2.1.2 Beta Emitters Market Performance (Value)
2.1.3 Brachytherapy Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Application 1 Market Performance (Volume)
3.1.2 Application 2 Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 IBA Group
4.1.1 IBA Group Profiles
4.1.2 IBA Group Product Information
4.1.3 IBA Group Nuclear Medicine Therapeutics Business Performance
4.1.4 IBA Group Nuclear Medicine Therapeutics Business Development and Market Status
4.2 Lantheus Medical Imaging
4.2.1 Lantheus Medical Imaging Profiles
4.2.2 Lantheus Medical Imaging Product Information
4.2.3 Lantheus Medical Imaging Nuclear Medicine Therapeutics Business Performance
4.2.4 Lantheus Medical Imaging Nuclear Medicine Therapeutics Business Development and Market Status
4.3 Triad Isotopes
4.3.1 Triad Isotopes Profiles
4.3.2 Triad Isotopes Product Information
4.3.3 Triad Isotopes Nuclear Medicine Therapeutics Business Performance
4.3.4 Triad Isotopes Nuclear Medicine Therapeutics Business Development and Market Status
4.4 Siemens Healthcare (PETNET Solutions)
4.4.1 Siemens Healthcare (PETNET Solutions) Profiles
4.4.2 Siemens Healthcare (PETNET Solutions) Product Information
4.4.3 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Business Performance
4.4.4 Siemens Healthcare (PETNET Solutions) Nuclear Medicine Therapeutics Business Development and Market Status
4.5 NTP Radioisotopes
4.5.1 NTP Radioisotopes Profiles
4.5.2 NTP Radioisotopes Product Information
4.5.3 NTP Radioisotopes Nuclear Medicine Therapeutics Business Performance
4.5.4 NTP Radioisotopes Nuclear Medicine Therapeutics Business Development and Market Status
5 Market Performance for Manufacturers
5.1 Global Nuclear Medicine Therapeutics Sales (K Units) and Market Share by Manufacturers 2013-2018
5.2 Global Nuclear Medicine Therapeutics Revenue (M USD) and Market Share by Manufacturers 2013-2018
5.3 Global Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
5.4 Global Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Nuclear Medicine Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
6.1.2 China Nuclear Medicine Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
6.1.3 China Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
6.1.4 China Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Nuclear Medicine Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
6.2.2 USA Nuclear Medicine Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
6.2.3 USA Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
6.2.4 USA Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Nuclear Medicine Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
6.3.2 Europe Nuclear Medicine Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
6.3.3 Europe Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
6.3.4 Europe Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Nuclear Medicine Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
6.4.2 Japan Nuclear Medicine Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
6.4.3 Japan Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
6.4.4 Japan Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Nuclear Medicine Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
6.5.2 Korea Nuclear Medicine Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
6.5.3 Korea Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
6.5.4 Korea Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Nuclear Medicine Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
6.6.2 India Nuclear Medicine Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
6.6.3 India Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
6.6.4 India Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Nuclear Medicine Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
6.7.2 Southeast Asia Nuclear Medicine Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
6.7.3 Southeast Asia Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
6.7.4 Southeast Asia Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Nuclear Medicine Therapeutics Sales (K Units) and Share of Manufacturers 2013-2018
6.8.2 South America Nuclear Medicine Therapeutics Revenue (M USD) and Share of Manufacturers 2013-2018
6.8.3 South America Nuclear Medicine Therapeutics Price (USD/Unit) of Manufacturers 2013-2018
6.8.4 South America Nuclear Medicine Therapeutics Gross Margin of Manufacturers 2013-2018
6.8.5 Market Concentration
7 Global Nuclear Medicine Therapeutics Market Performance (Sales Point)
7.1 Global Nuclear Medicine Therapeutics Sales (K Units) and Market Share by Regions 2013-2018
7.2 Global Nuclear Medicine Therapeutics Revenue (M USD) and Market Share by Regions 2013-2018
7.3 Global Nuclear Medicine Therapeutics Price (USD/Unit) by Regions 2013-2018
7.4 Global Nuclear Medicine Therapeutics Gross Margin by Regions 2013-2018
8 Development Trend for Regions (Sales Point)
8.1 Global Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
8.2 China Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
8.3 USA Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
8.4 Europe Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
8.5 Japan Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
8.6 Korea Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
8.7 India Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
8.8 Southeast Asia Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
8.8 Southeast Asia Nuclear Medicine Therapeutics Sales and Growth, Sales Value and Growth Rate2013-2018
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Application 1 Industry
11.2 Application 2 Industry
12 Market Forecast 2019-2024
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
12.1.1 Global Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
12.1.2 Global Nuclear Medicine Therapeutics Sales (K Units) and Growth Rate 2019-2024
12.1.3 China Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.4 USA Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.5 Europe Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.6 Japan Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.7 Korea Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.8 India Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.9 Southeast Asia Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.1.10 South America Nuclear Medicine Therapeutics Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
12.3.1 Overall Market Performance
12.3.2 Alpha Emitters Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3.3 Beta Emitters Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.3.4 Brachytherapy Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
12.4 Sales by Application 2019-2024
12.4.1 Overall Market Performance
12.4.2 Application 1 Sales and and Growth Rate 2019-2024
12.4.3 Application 2 Sales and and Growth Rate 2019-2024
12.5 Price (USD/Unit) and Gross Profit
12.5.1 Global Nuclear Medicine Therapeutics Price (USD/Unit) Trend 2019-2024
12.5.2 Global Nuclear Medicine Therapeutics Gross Profit Trend 2019-2024
13 Conclusion
Nuclear Medicine Therapeutics Sales
Nuclear Medicine Therapeutics Sales
×